FdaApplication
NDA 215320
Identifiers
- fda_app_no: NDA215320
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | NDA |
| approval_date | 2023-10-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COMBOGESIC IV | ACETAMINOPHEN; IBUPROFEN SODIUM | 1GM/100ML (10MG/ML);EQ 300MG BASE/100ML (EQ 3MG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product